Genzyme files another suit over Renagel patents
This article was originally published in Scrip
Executive Summary
Genzymehas filed a suit against ImpaxLaboratories in a US federal court in Maryland, alleging patent infringement related to its generic version of Renagel (sevelamer), one week after the company sued Lupin over its proposed generic version in another court (scripnews.com, March 10th, 2009).